Glucose Health(GLUC)
$0.44+0.13 (+41.94%)
GLUC
Glucose Health financials statements
$0.44
At close:+0.13 (+41.94%)
Glucose Health (GLUC) Ratios
38 Followers
Glucose Health Ratios
GLUC's free cash flow for Q2 2026 was $-77.15K. For the 2026 fiscal year, GLUC's free cash flow was increased by $0.00 and operating cash flow was $-77.15K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.64 | 0.78 | 2.80 | 28.28 | 120.65 |
| Quick Ratio | 1.64 | 0.14 | 1.58 | 13.84 | 92.62 |
| Cash Ratio | 1.11 | 0.07 | 1.45 | 12.72 | 78.74 |
| Solvency Ratio | -8.21 | -0.81 | -1.80 | -15.86 | -35.46 |
| Operating Cash Flow Ratio | -0.57 | -1.17 | -1.73 | -18.50 | -7.61 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -1.94 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 128.75K | $ -85.70K | $ 254.43K | $ 573.79K | $ 1.14M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.73 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | -3.61 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 1.38 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.19 | -4.96 | 1.55 | 1.04 | 1.01 |
| Debt Service Coverage Ratio | -5.38 | -1.25 | 0.00 | 0.00 | -120.67 |
| Interest Coverage Ratio | -5.46 | -32.70 | 0.00 | 0.00 | -120.69 |
| Debt to Market Cap | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.16 | -0.68 | 0.48 | 0.48 | 2.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 35.00% | 19.67% | 40.35% | 42.58% | 43.00% |
| EBIT Margin | -58.65% | -79.82% | -78.91% | -52.40% | -35.24% |
| EBITDA Margin | -57.88% | -79.53% | -78.91% | -52.40% | -35.24% |
| Operating Profit Margin | -58.65% | -79.82% | -78.91% | -52.40% | -35.24% |
| Pretax Profit Margin | -67.72% | -82.26% | -78.91% | -52.40% | -35.54% |
| Net Profit Margin | -67.72% | -82.26% | -78.91% | -52.40% | -35.54% |
| Continuous Operations Profit Margin | -67.72% | -82.26% | -78.91% | -52.40% | -35.54% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 115.46% | 103.06% | 100.00% | 100.00% | 100.83% |
| Return on Assets (ROA) | -132.16% | -98.02% | -105.81% | -93.98% | -29.31% |
| Return on Equity (ROE) | -157.16% | 486.01% | -163.72% | -97.41% | -29.56% |
| Return on Capital Employed (ROCE) | -136.11% | 471.58% | -163.72% | -97.41% | -29.32% |
| Return on Invested Capital (ROIC) | -136.11% | -181.00% | -163.72% | -97.41% | -29.32% |
| Return on Tangible Assets | -134.71% | -99.03% | -106.69% | -94.50% | -29.40% |
| Earnings Yield | -6.07% | -15.46% | -8.86% | -6.58% | -1.60% |
| Efficiency Ratios | |||||
| Receivables Turnover | 27.22 | 24.17 | 27.68 | 45.36 | 32.40 |
| Payables Turnover | 9.40 | 18.76 | 3.86 | 29.28 | 56.90 |
| Inventory Turnover | 2.00 | 1.24 | 1.85 | 2.03 | 2.03 |
| Fixed Asset Turnover | 23.09 | 22.07 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 1.95 | 1.19 | 1.34 | 1.79 | 0.82 |
| Working Capital Turnover Ratio | 15.83 | 4.55 | 1.29 | 1.25 | 1.61 |
| Cash Conversion Cycle | 157.51 | 290.37 | 115.87 | 175.55 | 184.69 |
| Days of Sales Outstanding | 13.41 | 15.10 | 13.19 | 8.05 | 11.27 |
| Days of Inventory Outstanding | 182.93 | 294.73 | 197.14 | 179.97 | 179.84 |
| Days of Payables Outstanding | 38.83 | 19.46 | 94.46 | 12.47 | 6.42 |
| Operating Cycle | 196.34 | 309.83 | 210.33 | 188.02 | 191.11 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.03 | -0.01 | -0.03 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.03 | -0.01 | -0.03 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -12.20 | -12.30 | -4.06 | -0.73 |
| Capital Expenditure Coverage Ratio | 0.00 | -24.60 | -48757.00 | -97288.48 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | -1.94 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.05 | -1.18 | -0.46 | -0.36 | -0.08 |
| Free Cash Flow Yield | -0.41% | -23.18% | -5.12% | -4.55% | -0.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.17 | -4.74 | -11.28 | -15.20 | -62.70 |
| Price-to-Sales (P/S) Ratio | 11.16 | 5.32 | 8.90 | 7.96 | 22.28 |
| Price-to-Book (P/B) Ratio | 25.90 | -31.43 | 18.47 | 14.80 | 18.53 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -241.42 | -4.31 | -19.53 | -21.95 | -292.11 |
| Price-to-Operating Cash Flow Ratio | -241.41 | -4.49 | -19.53 | -21.95 | -292.11 |
| Price-to-Earnings Growth (PEG) Ratio | 0.39 | 0.34 | 0.32 | -0.21 | 1.30 |
| Enterprise Value Multiple | -19.13 | -7.37 | -10.80 | -14.72 | -60.99 |
| Enterprise Value | 3.77M | 2.25M | 4.56M | 8.28M | 20.50M |
| EV to EBITDA | -19.13 | -7.37 | -10.80 | -14.72 | -60.99 |
| EV to Sales | 11.07 | 5.86 | 8.52 | 7.72 | 21.49 |
| EV to Free Cash Flow | -239.47 | -4.75 | -18.69 | -21.27 | -281.76 |
| EV to Operating Cash Flow | -239.46 | -4.95 | -18.69 | -21.27 | -281.76 |
| Tangible Book Value Per Share | 0.01 | -0.00 | 0.01 | 0.04 | 0.09 |
| Shareholders’ Equity Per Share | 0.01 | -0.00 | 0.02 | 0.04 | 0.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.02 | 0.02 | 0.03 | 0.07 | 0.07 |
| Net Income Per Share | -0.01 | -0.02 | -0.02 | -0.04 | -0.03 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.15 | 1.03 | 1.00 | 1.00 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.94 | 0.98 | 0.00 | 0.00 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 |
| Income Quality | 0.07 | 1.44 | 0.58 | 1.45 | 0.21 |
Currency in USD
